I A Volchegorskiĭ Selected Research

Experimental Diabetes Mellitus

1/2014	[Anxiolytic and antidepressant effects of 3-oxypiridine and succinic acid derivatives in the acute phase of alloxan-induced diabetes in rats].
1/2013	[Cerebroprotective effect of 3-oxypyridine and succinic acid derivatives in experimental diabetes mellitus].
1/2011	[Antihypoxic effect of 3-hydroxypyridine and succinic acid derivatives and their nootropic action in alloxan diabetes].
1/2011	[Cerebroprotective effect of 3-oxypyridine and succinic acid derivatives in acute phase of alloxan-induced diabetes mellitus in rats].
3/2009	[Antidepressant action of emoxipin and mexidol in mice with alloxan diabetes].
11/2008	[Antianemic effect of reamberin in rats with acute alloxan-induced diabetes].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

I A Volchegorskiĭ Research Topics

Disease

8	Diabetes Mellitus 05/2012 - 01/2003
6	Experimental Diabetes Mellitus 01/2014 - 11/2008
6	Hyperglycemia 01/2014 - 03/2009
5	Tuberculosis (Tuberculoses) 01/2013 - 01/2007
4	Mood Disorders (Mood Disorder) 01/2014 - 01/2005
4	Hyperlipidemias (Hyperlipidemia) 01/2011 - 01/2007
4	Diabetic Foot 01/2008 - 01/2004
3	Diabetic Neuropathies (Diabetic Neuropathy) 01/2014 - 01/2008
3	Pulmonary Tuberculosis 01/2013 - 01/2007
3	Hypoxia (Hypoxemia) 01/2011 - 03/2000
2	Inflammation (Inflammations) 01/2013 - 01/2002
2	Open-Angle Glaucoma (Glaucoma, Open Angle) 07/2012 - 01/2012
2	Neuralgia (Stump Neuralgia) 01/2010 - 01/2010
2	Intervertebral Disc Displacement (Herniated Disc) 01/2010 - 01/2010
2	Polyneuropathies (Polyneuropathy) 01/2008 - 01/2005
2	Prostatic Hyperplasia (Benign Prostatic Hyperplasia) 01/2002 - 01/2001
1	Ischemia 01/2014
1	Insulin Coma 01/2014
1	Brain Ischemia (Cerebral Ischemia) 01/2014
1	Depressive Disorder (Melancholia) 01/2014
1	hypoglycemic encephalopathy 04/2013
1	Fatigue 01/2013
1	Rheumatoid Arthritis 01/2013
1	Asthenia 01/2013
1	Chest Pain (Chest Pains) 01/2013
1	Learning Disabilities (Learning Disability) 01/2011
1	Cognitive Dysfunction 01/2011
1	Multiple Organ Failure (MODS) 09/2010
1	Nociceptive Pain 01/2010
1	Chronic Periodontitis 01/2010
1	Neurologic Manifestations (Neurological Manifestations) 01/2010
1	Pain (Aches) 01/2010
1	Anemia 11/2008
1	Leukocytosis (Pleocytosis) 11/2008
1	Hypesthesia (Numbness) 01/2008
1	Paresthesia (Dysesthesia) 01/2008
1	Spasm (Spasms) 01/2008
1	Hepatitis 01/2005
1	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 04/2003
1	Arteriosclerosis 01/2003
1	Cardiomyopathies (Cardiomyopathy) 01/2003
1	Diabetes Complications 01/2003
1	Dyslipidemias (Dyslipidemia) 01/2003
1	Dilated Cardiomyopathy (Cardiomyopathy, Congestive) 01/2003
1	Heart Failure 01/2003
1	Hypertrophic Cardiomyopathy (Hypertrophic Obstructive Cardiomyopathy) 02/2002
1	Burns 01/2002
1	Peritonitis 03/2000

Drug/Important Bio-Agent (IBA)

18	6-methyl-2-ethyl-3-hydroxypyridineIBA 01/2014 - 01/2004
17	emoxypine succinateIBA 01/2014 - 01/2005
13	Succinic Acid (Succinate)IBA 01/2014 - 01/2004
11	ReamberinIBA 01/2014 - 01/2005
7	AlloxanIBA 01/2014 - 01/2005
7	Thioctic Acid (Lipoic Acid)IBA 01/2014 - 01/2008
6	3-oxypyridineIBA 01/2014 - 01/2007
6	AntioxidantsIBA 07/2012 - 01/2003
5	3-hydroxypyridineIBA 01/2012 - 01/2004
4	Lipid PeroxidesIBA 01/2013 - 01/2002
4	Ceruloplasmin (Ferroxidase)IBA 04/2003 - 01/2001
3	Antidepressive Agents (Antidepressants)IBA 01/2014 - 03/2009
3	alpha-Tocopherol FDA Link 05/2012 - 01/2003
2	ThymolIBA 01/2013 - 01/2013
2	Ascorbic Acid (Vitamin C)FDA LinkGeneric 01/2009 - 01/2007
1	Insulin (Novolin)FDA Link 01/2014
1	Anti-Anxiety Agents (Anxiolytics)IBA 01/2014
1	Retinaldehyde (Retinal)IBA 07/2012
1	HeptanesIBA 05/2012
1	LipidsIBA 05/2012
1	CholesterolIBA 05/2012
1	Neuroprotective AgentsIBA 01/2011
1	Nootropic Agents (Nootropics)IBA 01/2011
1	Pharmaceutical PreparationsIBA 01/2010
1	Indicators and Reagents (Reagents)IBA 01/2008
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2007
1	CytokinesIBA 01/2007
1	Triamcinolone Acetonide (Azmacort)FDA LinkGeneric 01/2005
1	Deoxycytidine Monophosphate (DCMP)IBA 01/2003
1	HDL LipoproteinsIBA 01/2003
1	FructosamineIBA 01/2003
1	sephadexIBA 01/2002
1	Starch (Cornstarch)IBA 03/2000
1	Monoamine Oxidase (MAO)IBA 03/2000

Therapy/Procedure

4	Therapeutics 01/2013 - 01/2007
2	Conservative Treatment 01/2013 - 01/2013
1	Drug Therapy (Chemotherapy) 01/2009